Syngulon reposted this
It was a pleasure participating in today's panel discussion at #BioFIT2024 in Lille, France. Thanks to the organizers for the opportunity to share my experience as a biotech startup in licensing deals. It was great discussing with the co-panelists (large pharma + TTO) and the moderator.
🌟 Reflections on deal-making in biotech: Highlights from #BioFIT2024 Today’s session, “Navigating a deal structure: Overview, market practices, and how to approach,” explored the evolving dynamics of biotech deal-making. Our panel shared insights on innovative licensing models, the impact of technology and therapeutic focus on partnerships, and how pharma’s asset selection is adapting to industry innovation. A huge thank you to our speakers for their expertise and thought-provoking contributions: 🔹 Christopher Shelley (Penningtons Manches Cooper LLP) 🔹 Tamar Raz (Hadasit Medical Research Services & Development) 🔹 Lilian Alcaraz (Johnson & Johnson) 🔹 Guy Hélin (Syngulon) This session highlighted the power of collaboration and strategic foresight to drive innovation forward! 🚀 #Biotech #Pharma #Innovation #DealMaking